The NOVOstar is an affordable alternative to perform complex cell-based kinetic microplate assays such as calcium or ion channel. Previously, kinetic cell-based assays required the use of expensive HTS equipment, which lead to limited accessibility for scientists in the assay development stage. The NOVOstar offers the perfect equipment necessary for cell-based assays and research development, as well as the tools necessary to perform any other assay suitable for the microplate format.
Wide range of applications Due to its integrated programmable micropipetting system and plate-to-plate transfer, the NOVOstar is well-suited to screen large numbers of compounds in kinetic cell-based assays, or it can create a dose response curve by measuring a wide range of compound concentrations. NOVOstar applications include:
• Ca2+ measurements (e.g. Ca2+flux with Fura-2, Indo-1, FLUO-3/4) • Membrane potential studies • Ion channel assays • Intracellular pH • Fluorescent reporter gene assays • Traditional fluorescence assays involving up to eight excitation and emission pairs.
Exceptional technology The NOVOstar achieves its functionality through the use of exceptional technology. It has a dual microplate carrier that allows users to designate a reagent microplate and a measurement microplate. A transfer micropipette easily allows for plate-to-plate transfers and two additional reagent injectors provide flexibility in assay design. Incubation up to 45°C or 60°C, shaking, user-defined kinetic sampling rates, and bottom reading are all features on the NOVOstar.
Detection modes • Fluorescence Polarization • Fluorescence Intensity - including FRET • Time-Resolved Fluorescence - including DELFIA® • High-Performance Luminescence (flash and glow) - DLReady™ certified • Absorbance - UV/Vis with path length correction
Software package The NOVOstar Omega license-free software includes the NOVOstar Reader Control and the MARS Data Analysis software. This highly intuitive software provides limitless possibilities for test set-up and data analysis, while also offering a Quick Start shortcut for running routine tests and calculation templates for data analyses.
Charting Kidney Cancer Metabolism Changes in cell metabolism are increasingly recognized as an important way tumors develop and progress, yet these changes are hard to measure and interpret. A new tool designed by MSK scientists allows users to identify metabolic changes in kidney cancer tumors that may one day be targets for therapy.Insights into the Function of the Main Class of Drug Targets About thirty percent of all medical drugs such as beta-blockers or antidepressants interact with certain types of cell surface proteins called G protein coupled receptors.Visualizing a Cancer Drug Target at Atomic Resolution Using cryo-electron microscopy, researchers were able to view, in atomic detail, the binding of a potential small molecule drug to a key protein in cancer cells.Honey’s Potential to Save Lives The healing powers of honey have been known for thousands of years. 3-D Printed Lifelike Liver Tissue for Drug Screening A team led by engineers at the University of California, San Diego has 3D-printed a tissue that closely mimics the human liver's sophisticated structure and function. The new model could be used for patient-specific drug screening and disease modeling. Cytoskeleton Crew Findings confirm sugar's role in helping cancers survive by changing cellular architecture.Biomarker for Recurring HPV-Linked Oropharyngeal Cancers A look-back analysis of HPV infection antibodies in patients treated for oropharyngeal (mouth and throat) cancers linked to HPV infection suggests at least one of the antibodies could be useful in identifying those at risk for a recurrence of the cancer, say scientists at the Johns Hopkins University. Valvena, GSK Sign New R&D Collaboration Valneva to supply process development services for EB66® -based Influenza vaccines. Light Signals from Living Cells Fluorescent protein markers delivered under high pressure.Cellular 'Relief Valve' A team led by scientists at The Scripps Research Institute (TSRI) has solved a long-standing mystery in cell biology by showing essentially how a key “relief-valve” in cells does its job.